Kelly C. Goldsmith, a physician-scientist specializing in pediatric oncology, has been named co-leader of the Discovery and Developmental Therapeutics Program, one of four research programs within Winship Cancer Institute of Emory University.
Madhusmita Behera was named the first chief informatics and data officer of Winship Cancer Institute of Emory University.
Aman Chhabra was named the first chief business officer of Winship Cancer Institute of Emory University.
Lali Medina Kauwe, has been appointed as co-program leader of the Cancer Biology Program within Cedars-Sinai Cancer at the Samuel Oschin Comprehensive Cancer Institute.
Pamela Kunz was named the 2021 Woman Oncologist of the Year by Women Leaders in Oncology.
Lynn Wilson has been named deputy chief medical officer for radiation oncology for Smilow Cancer Hospital at Yale New Haven and the Smilow Cancer Hospital Network.
Margaret Gilshannon was appointed deputy director for finance and administration at Yale Cancer Center.
Christian Linge of SafeBreast Communities from Oslo, Norway, donated $250,000 to the American Cancer Society’s Cancer Crypto Fund.
Researchers from Exscientia, the Medical University of Vienna, and the CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences demonstrated the impact of using Exscientia’s AI-supported precision medicine platform to propose which therapy would be most effective for late-stage hematological cancer patients, based on testing drug responses ex vivo in their own tissue samples.
Participants in a prospective, multi-center, randomized, crossover study (NILE – NCT04908254) reported significantly greater adherence to Dayspring treatment, an active compression treatment for lymphedema, in comparison to the use of pneumatic compression pump.
